课题基金 / 基金详情

Digital prescription integration platform between NHS funded charity and mail-order Pharmacy.

Digital prescription integration platform between NHS funded charity and mail-order Pharmacy.
NHS 资助的慈善机构和邮购药房之间的数字处方集成平台。
批准号:
69049
负责人:
金额:
$9.4万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们将建立一个定制的私人处方平台,与私人组织和NHS合同组织(如慈善机构)合作,上传处方,然后我们将使用完全跟踪和跟踪的递送将处方直接分发给消费者/患者。患者不需要去药房取药,甚至不需要去机构咨询。咨询可以由提供者远程进行,同时我们通过允许临床医生开出数字处方并通过安全网络传输到我们的技术来支持这一点,以便通过完全跟踪的交付安全地运送到患者家中。该平台将与PMR软件、Microsoft Dynamics BC ERP系统和药房内的运营商软件集成。该项目将初步将当前的“门诊”医疗模式转变为完全虚拟的,这将确保在新冠肺炎大流行期间服务的连续性。这项新服务可以超越封锁限制,并允许慈善机构提供在其组织中持续进行的远程医疗模式。保护临床医生、患者和药剂师的健康和福祉。其他信息:然后,我们需要为通过该平台接受治疗的所有患者启动身份验证流程,以满足法规遵从性(GPhC;CQC;NHS)和改进,并允许我们将服务推广到英国更广泛的患者群体。这意味着可以为患者提供更多远程服务,以减少新冠肺炎带来的影响/干扰。
英文摘要
We will be building a bespoke private prescription platform that works with both private organisations and NHS contracted organisations such as charities to upload prescriptions that we will subsequently dispense direct to consumer/patient using fully tracked and traced delivery.Eliminating the need for the patient to visit the pharmacy to collect medicines or indeed visit the organisations for a consultation. The consultation can be carried out remotely by the provider, whilst we support this with technology that allows the clinician to write a digital prescription and transmit to us through a secure network for safe shipment to the patients home via fully tracked delivery.The platform will integrate with PMR software, Microsoft Dynamics BC ERP system and carrier software within the Pharmacy.This project will initially move a current "in-clinic" healthcare model to completely virtual, which will ensure continuity of service during the COVID-19 pandemic. This new service can extend beyond the lockdown restrictions and allows the charity to offer a remote healthcare model ongoing in their organisation. Protecting the health and well-being of both clinician, patient and pharmacist.Additional Info:We then need to move towards launching Identity verification processes for all patients that are treated through the platform to meet regulatory compliance (GPHC; CQC; NHS) & improvement and allow us to roll the service out to a wider patient population across the UK. Meaning more remote services can be used for patients reducing the impact/disruption posed by COVID-19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金